Celltrion
Celltrion
Explore linked clinical trials.14 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TIDHI Mental Health in IBD Patients Study | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Not applicable | 2026-09-29 | NCT07013578 | |
| Zymfentra (Infliximab-dyyb) REal World Cohort STudy | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, indeterminate colitis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Not stated | 2026-08-05 | NCT07237516 | |
| A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer | Non Squamous Non Small Cell Lung Cancer | Active, not recruiting | Phase 3 | 2026-07-08 | NCT06939595 | |
| Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL. | primary central nervous system lymphoma | Recruiting | Phase 2 | 2026-04-23 | NCT04627753 | |
| A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps | Axial Spondyloarthritis, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, rheumatic disorder, rheumatoid arthritis, skin disorder, spondylitis, vertebral column disorder | Active, not recruiting | Not stated | 2026-03-31 | NCT05866614 | |
| A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis | Plaque Psoriasis | Active, not recruiting | Phase 3 | 2026-02-23 | NCT06630559 | |
| Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects | Healthy Participants | Active, not recruiting | Phase 1 | 2025-12-31 | NCT07200986 | |
| A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2025-08-15 | NCT06952478 | |
| Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 3 | 2025-08-11 | NCT07093476 | |
| Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes | Digestive System Diseases, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, liver disorder, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 4 | 2025-05-25 | NCT06989723 | |
| A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Not applicable | 2025-04-24 | NCT06627322 | |
| InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, inflammatory disease, intestinal disorder | Recruiting | Phase 3 | 2024-12-10 | NCT06059989 | |
| Subcutaneous Infliximab After A Previous Intravenous Dose Optimization | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 4 | 2024-07-26 | NCT06113913 | |
| A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Recruiting | Phase 3 | 2024-05-22 | NCT05906992 |